Your search returned 12 results.

Results
	1.	Intractable hiccups induced by the use of megestrol acetate. [electronic resource] by Pertel, P Till, M Producer: 19980423 In: Archives of internal medicine vol. 158 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Adverse reactions to dapsone in persons infected with human immunodeficiency virus. [electronic resource] by Pertel, P Hirschtick, R Producer: 19940824 In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Partial resistance to gD-mediated interference conferred by mutations affecting herpes simplex virus type 1 gC and gK. [electronic resource] by Pertel, P E Spear, P G Producer: 19971020 In: Journal of virology vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition. [electronic resource] by Pertel, P E Spear, P G Producer: 19970102 In: Virology vol. 226 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Human herpesvirus-8 glycoprotein B interacts with Epstein-Barr virus (EBV) glycoprotein 110 but fails to complement the infectivity of EBV mutants. [electronic resource] by Pertel, P E Spear, P G Longnecker, R Producer: 19990104 In: Virology vol. 251 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. [electronic resource] by Pertel, P E Fridberg, A Parish, M L Spear, P G Producer: 20010301 In: Virology vol. 279 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. [electronic resource] by Pertel, P Hirschtick, R Phair, J Chmiel, J Poggensee, L Murphy, R Producer: 19921110 In: Journal of acquired immune deficiency syndromes vol. 5 Availability: No items available. Save to lists Add to cart (remove)
	8.	Complicated urinary tract infections treated with extended-release ciprofloxacin with emphasis on Pseudomonas aeruginosa. [electronic resource] by Saltzstein, D Wachs, B Perroncel, R Benson, A Herrington, J Haverstock, D Pertel, P Producer: 20080715 In: Journal of chemotherapy (Florence, Italy) vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Acute bacterial maxillary sinusitis: time to symptom resolution and return to normal activities with moxifloxacin. [electronic resource] by Johnson, P Adelglass, J Rankin, B Sterling, R Keating, K Benson, A Pertel, P Producer: 20090507 In: International journal of clinical practice vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis. [electronic resource] by Benziger, D P Pertel, P E Donovan, J Yankelev, S Schwab, R J Swan, S K Cannon, C Producer: 20110209 In: Clinical nephrology vol. 75 Availability: No items available. Save to lists Add to cart (remove)
	11.	The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas. [electronic resource] by Pertel, P E Eisenstein, B I Link, A S Donfrid, B Biermann, E J A Bernardo, P Martone, W J Producer: 20090511 In: International journal of clinical practice vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	The value, qualification, and regulatory use of surrogate end points in drug development. [electronic resource] by Lathia, C D Amakye, D Dai, W Girman, C Madani, S Mayne, J MacCarthy, P Pertel, P Seman, L Stoch, A Tarantino, P Webster, C Williams, S Wagner, J A Producer: 20090723 In: Clinical pharmacology and therapeutics vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)